Back

Q&A

27 August 2023 (16:09 - 16:15)
Organised by: Logo
Congress Presentation Part of: Why does an expanding data and product portfolio position lytic-free thrombectomy as the first choice for acute pulmonary embolism (PE) treatment? Acute Pulmonary Embolism Open Access ESC Congress 2023 European Society of Cardiology

3 More presentations in this session

Presentation thumbnail
Risk stratification of intermediate risk pulmonary embolism: importance of normotensive shock
Professor S. Bangalore (New York, US)
Slides Video
Presentation thumbnail
New datasets impacting the status quo of the treatment of intermediate-high pulmonary embolism patients- FLASH, PEERLESS and PEERLESS II
Professor F. Mahfoud (Basel, CH)
Slides Video
Presentation thumbnail
How does FLAME data improve the management of high-risk pulmonary embolism patients?
Doctor C. Toma (Pittsburgh, US)
Slides Video

Access the full session

Session thumbnail
Why does an expanding data and product portfolio position lytic-free thrombectomy as the first choice for acute pulmonary embolism (PE) treatment?
Video

The Event

Event poster

ESC Congress 2023

27 August 2023 16:09 CET
You may be interested in
thumbnail
Congress Presentation
ESC Andreas Grüntzig Lecture in Interventional Cardiology - Q&A
27 August 2023
thumbnail
Congress Session
Arrhythmia diagnosis and therapy: from implantable cardiac monitoring to cardiac pacing
31 March 2025
thumbnail
Congress Session
Evolution of coronary artery disease diagnosis ... from stenosis to inflammation
30 August 2024
thumbnail
Congress Session
Choose the right workflow for your AF patients - Live cases with Varipulse, QDOT and Optrell
31 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources